N. Saijo

1.2k total citations
62 papers, 980 citations indexed

About

N. Saijo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, N. Saijo has authored 62 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 21 papers in Molecular Biology. Recurrent topics in N. Saijo's work include Lung Cancer Treatments and Mutations (29 papers), Cancer therapeutics and mechanisms (16 papers) and Lung Cancer Research Studies (16 papers). N. Saijo is often cited by papers focused on Lung Cancer Treatments and Mutations (29 papers), Cancer therapeutics and mechanisms (16 papers) and Lung Cancer Research Studies (16 papers). N. Saijo collaborates with scholars based in Japan, United Kingdom and United States. N. Saijo's co-authors include Ikuo Sekine, Hideo Kunitoh, Tomohide Tamura, Koichi Tokuuye, Minako Sumi, Ayumu Hoshi, Masanori Sakurai, Fumihiko Kanzawa, Yutaka Nishiwaki and Haruyuki Fukuda and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

N. Saijo

59 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Saijo Japan	16	520	438	332	131	101	62	980
K.A. Mason United States	11	687 1.3×	440 1.0×	288 0.9×	123 0.9×	39 0.4×	18	1.3k
B. F. El-Rayes United States	19	615 1.2×	385 0.9×	348 1.0×	71 0.5×	32 0.3×	38	1.2k
Eugenio Villa Italy	14	676 1.3×	396 0.9×	215 0.6×	104 0.8×	23 0.2×	20	973
Chung-Tsen Hsueh United States	19	556 1.1×	305 0.7×	416 1.3×	43 0.3×	87 0.9×	55	1.2k
Jian He China	15	271 0.5×	341 0.8×	259 0.8×	99 0.8×	75 0.7×	45	828
Michael Xiang United States	16	351 0.7×	295 0.7×	475 1.4×	51 0.4×	104 1.0×	68	1.1k
E. Levchenko Russia	12	510 1.0×	451 1.0×	341 1.0×	63 0.5×	147 1.5×	75	908
Jurgita Sauvageot United States	8	298 0.6×	826 1.9×	546 1.6×	57 0.4×	72 0.7×	12	1.4k
Maria Q. Baggstrom United States	17	743 1.4×	922 2.1×	406 1.2×	152 1.2×	37 0.4×	65	1.5k
Denise McLain United States	14	288 0.6×	223 0.5×	240 0.7×	69 0.5×	157 1.6×	32	690

Countries citing papers authored by N. Saijo

Since Specialization

Citations

This map shows the geographic impact of N. Saijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Saijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Saijo more than expected).

Fields of papers citing papers by N. Saijo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Saijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Saijo. The network helps show where N. Saijo may publish in the future.

Co-authorship network of co-authors of N. Saijo

This figure shows the co-authorship network connecting the top 25 collaborators of N. Saijo. A scholar is included among the top collaborators of N. Saijo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Saijo. N. Saijo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taniguchi, Yoshihiko, N. Saijo, Akihiro Tamiya, et al.. (2017). The efficacy of a reduced dose (40mg) of osimertinib with T790M-positive advanced non-small-cell lung cancer. Annals of Oncology. 28. x130–x130. 6 indexed citations

Yamamoto, Nobuyuki, Ikuo Sekine, Katsuhiro Nakagawa, et al.. (2009). A Pharmacokinetic and Dose Escalation Study of Pegfilgrastim (KRN125) in Lung Cancer Patients with Chemotherapy-induced Neutropenia. Japanese Journal of Clinical Oncology. 39(7). 425–430. 14 indexed citations

Nokihara, Hiroshi, Terufumi Kato, Nobuyuki Yamamoto, et al.. (2006). A randomized phase II study of sequential carboplatin/paclitaxel (CP) and gefitinib (G) in chemotherapy-naïve patients with advanced non-small-cell lung cancer (NSCLC): Preliminary results. Journal of Clinical Oncology. 24(18_suppl). 7096–7096. 8 indexed citations

Sekine, Ikuo, Hiroshi Nokihara, Noboru Yamamoto, et al.. (2004). Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma. British Journal of Cancer. 90(6). 1125–1128. 14 indexed citations

Kunitoh, Hideo, et al.. (2001). Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. International Journal of Radiation Oncology*Biology*Physics. 49(3). 649–655. 147 indexed citations

Kubota, Kayoko, Yuichiro Ohe, Hajime Watanabe, et al.. (2000). Phase I study of weekly docetaxel (DTX) and carboplatin (CBDCA) with concurrent thoracic radiotherapy (TRT) for stage III non-small cell lung cancer (NSCLC). Lung Cancer. 29(1). 111–111. 9 indexed citations

Kanzawa, Fumihiko, et al.. (1999). In vitro interactions of a new derivative of spicamycin, KRN5500, and other anticancer drugs using a three-dimensional model. Cancer Chemotherapy and Pharmacology. 43(5). 353–363. 11 indexed citations

Shimoyama, M, Haruhiko Fukuda, N. Saijo, & Nobuyasu Yamaguchi. (1998). Japan Clinical Oncology Group (JCOG). Japanese Journal of Clinical Oncology. 28(3). 158–162. 32 indexed citations

Ohe, Yuichiro, Kazuto Nishio, Hideo Kunitoh, et al.. (1998). Factors that Influence the Eligibility of Cases for Inclusion in Clinical Trials. Japanese Journal of Clinical Oncology. 28(3). 214–221. 2 indexed citations

10.

Asamoto, H, Manabu Kawahara, Mutsuo Kuba, et al.. (1998). Cisplatin Plus Oral Etoposide in the Treatment of Patients with Advanced Small Cell Lung Cancer. Japanese Journal of Clinical Oncology. 28(12). 745–748. 4 indexed citations

11.

Kanzawa, Fumihiko, Kazuto Nishio, Kazuya Fukuoka, et al.. (1997). Evaluation of synergism by a novel three-dimensional model for the combined action of cisplatin and etoposide on the growth of a human small-cell lung-cancer cell line, SBC-3. International Journal of Cancer. 71(3). 311–319. 25 indexed citations

12.

Kanzawa, Fumihiko, et al.. (1995). Intracellular Carboxyl Esterase Activity Is a Determinant of Cellular Sensitivity to the Antineoplastic Agent KW‐2189 in Cell Lines Resistant to Cisplatin and CPT‐11. Japanese Journal of Cancer Research. 86(1). 124–129. 39 indexed citations

13.

Oshita, Fumihiro, Norio Yamamoto, Minoru Fukuda, et al.. (1995). Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro. Lung Cancer. 13(2). 220–220. 15 indexed citations

14.

Takeda, Yuichiro, et al.. (1994). A Novel Antitumor Antibiotic, KW‐2189 Is Activated by Carboxyl Esterase and Induces DNA Strand Breaks in Human Small Cell Lung Cancer Cells. Japanese Journal of Cancer Research. 85(4). 418–425. 31 indexed citations

15.

Nishio, Kazuto, Tai Ohmori, Yuichiro Takeda, et al.. (1993). Novel Water-Soluble Derivatives of Docosahexaenoic Acid Increase Diacylglycerol Production Mediated by Phosphatidylcholine-Specific Phospholipase C. Experimental Biology and Medicine. 203(2). 200–208. 1 indexed citations

16.

Nakagawa, Kazuhiko, et al.. (1992). Participation of poly(ADP-robose) polymerase in the drug sensitivity in human lung cancer cell lines. Journal of Cancer Research and Clinical Oncology. 118(4). 244–248. 11 indexed citations

17.

Sasaki, Yasutsuna, Masaaki Fukuda, Tetsu Shinkai, et al.. (1990). Prediction from Creatinine Clearance of Thrombocytopenia and Recommended Dose in Patients Receiving (Glycolato‐O, O′)‐diammine Platinum (II) (NSC 375101D). Japanese Journal of Cancer Research. 81(2). 196–200. 15 indexed citations

18.

Eguchi, K., N. Saijo, Tetsu Shinkai, et al.. (1987). [Recent status of the diagnosis and treatment of bone metastasis in patients with advanced lung cancer].. PubMed. 14(5 Pt 2). 1696–703. 3 indexed citations

19.

Saijo, N., et al.. (1983). [Effect of Nocardia rubra cell wall skeleton against pleuritis carcinomatosa in adenocarcinoma of the lung].. PubMed. 10(2 Pt). 290–5. 4 indexed citations

20.

Shibuya, Masabumi, et al.. (1983). [Effect of C-reactive protein on natural killer activity].. PubMed. 10(11). 2341–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact